Global Influenza Virus Vaccine (H1N1) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Influenza Virus Vaccine (H1N1) by Country/Region, 2017, 2022 & 2028

2.2 Influenza Virus Vaccine (H1N1) Segment by Type

2.2.1 Intramuscular Vaccine

2.2.2 Nasal Spray Vaccine

2.3 Influenza Virus Vaccine (H1N1) Sales by Type

2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)

2.3.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2017-2022)

2.4 Influenza Virus Vaccine (H1N1) Segment by Application

2.4.1 3 To 10 Years Old

2.4.2 10 To 18 Years Old

2.4.3 Above 18 Years Old

2.4.4 Other

2.5 Influenza Virus Vaccine (H1N1) Sales by Application

2.5.1 Global Influenza Virus Vaccine (H1N1) Sale Market Share by Application (2017-2022)

2.5.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2017-2022)

3 Global Influenza Virus Vaccine (H1N1) by Company

3.1 Global Influenza Virus Vaccine (H1N1) Breakdown Data by Company

3.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Company (2020-2022)

3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2020-2022)

3.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Company (2020-2022)

3.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Company (2020-2022)

3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2020-2022)

3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Company

3.4 Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Influenza Virus Vaccine (H1N1) Product Location Distribution

3.4.2 Players Influenza Virus Vaccine (H1N1) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Influenza Virus Vaccine (H1N1) by Geographic Region

4.1 World Historic Influenza Virus Vaccine (H1N1) Market Size by Geographic Region (2017-2022)

4.1.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Geographic Region

4.2 World Historic Influenza Virus Vaccine (H1N1) Market Size by Country/Region (2017-2022)

4.2.1 Global Influenza Virus Vaccine (H1N1) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue by Country/Region

4.3 Americas Influenza Virus Vaccine (H1N1) Sales Growth

4.4 APAC Influenza Virus Vaccine (H1N1) Sales Growth

4.5 Europe Influenza Virus Vaccine (H1N1) Sales Growth

4.6 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Growth

5 Americas

5.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country

5.1.1 Americas Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022)

5.1.2 Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022)

5.2 Americas Influenza Virus Vaccine (H1N1) Sales by Type

5.3 Americas Influenza Virus Vaccine (H1N1) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region

6.1.1 APAC Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022)

6.1.2 APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022)

6.2 APAC Influenza Virus Vaccine (H1N1) Sales by Type

6.3 APAC Influenza Virus Vaccine (H1N1) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Influenza Virus Vaccine (H1N1) by Country

7.1.1 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022)

7.1.2 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022)

7.2 Europe Influenza Virus Vaccine (H1N1) Sales by Type

7.3 Europe Influenza Virus Vaccine (H1N1) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Influenza Virus Vaccine (H1N1) by Country

8.1.1 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022)

8.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type

8.3 Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Influenza Virus Vaccine (H1N1)

10.3 Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)

10.4 Industry Chain Structure of Influenza Virus Vaccine (H1N1)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Influenza Virus Vaccine (H1N1) Distributors

11.3 Influenza Virus Vaccine (H1N1) Customer

12 World Forecast Review for Influenza Virus Vaccine (H1N1) by Geographic Region

12.1 Global Influenza Virus Vaccine (H1N1) Market Size Forecast by Region

12.1.1 Global Influenza Virus Vaccine (H1N1) Forecast by Region (2023-2028)

12.1.2 Global Influenza Virus Vaccine (H1N1) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Influenza Virus Vaccine (H1N1) Forecast by Type

12.7 Global Influenza Virus Vaccine (H1N1) Forecast by Application

13 Key Players Analysis

13.1 CSL

13.1.1 CSL Company Information

13.1.2 CSL Influenza Virus Vaccine (H1N1) Product Offered

13.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CSL Main Business Overview

13.1.5 CSL Latest Developments

13.2 NVS(Novartis)

13.2.1 NVS(Novartis) Company Information

13.2.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Offered

13.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 NVS(Novartis) Main Business Overview

13.2.5 NVS(Novartis) Latest Developments

13.3 Sanofi Pasteur

13.3.1 Sanofi Pasteur Company Information

13.3.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Offered

13.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Pasteur Main Business Overview

13.3.5 Sanofi Pasteur Latest Developments

13.4 Medimmune

13.4.1 Medimmune Company Information

13.4.2 Medimmune Influenza Virus Vaccine (H1N1) Product Offered

13.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Medimmune Main Business Overview

13.4.5 Medimmune Latest Developments

13.5 GSK

13.5.1 GSK Company Information

13.5.2 GSK Influenza Virus Vaccine (H1N1) Product Offered

13.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GSK Main Business Overview

13.5.5 GSK Latest Developments

13.6 Baxter

13.6.1 Baxter Company Information

13.6.2 Baxter Influenza Virus Vaccine (H1N1) Product Offered

13.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Baxter Main Business Overview

13.6.5 Baxter Latest Developments

13.7 Beijing Kexing Bio-Vaccine

13.7.1 Beijing Kexing Bio-Vaccine Company Information

13.7.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered

13.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Beijing Kexing Bio-Vaccine Main Business Overview

13.7.5 Beijing Kexing Bio-Vaccine Latest Developments

13.8 Hualan Bio-Vaccine

13.8.1 Hualan Bio-Vaccine Company Information

13.8.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered

13.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hualan Bio-Vaccine Main Business Overview

13.8.5 Hualan Bio-Vaccine Latest Developments

13.9 Changchun Changsheng Bio-Technology

13.9.1 Changchun Changsheng Bio-Technology Company Information

13.9.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered

13.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Changchun Changsheng Bio-Technology Main Business Overview

13.9.5 Changchun Changsheng Bio-Technology Latest Developments

13.10 Beijing Tiantan Bio-Products

13.10.1 Beijing Tiantan Bio-Products Company Information

13.10.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Offered

13.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Beijing Tiantan Bio-Products Main Business Overview

13.10.5 Beijing Tiantan Bio-Products Latest Developments

13.11 Jiangsu Yanshen Bio-Technology

13.11.1 Jiangsu Yanshen Bio-Technology Company Information

13.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered

13.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Jiangsu Yanshen Bio-Technology Main Business Overview

13.11.5 Jiangsu Yanshen Bio-Technology Latest Developments

13.12 Zhejiang Tianyuan Bio-Pharmaceutical

13.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information

13.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered

13.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview

13.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments

13.13 Dalian Yalifeng Bio-Pharmaceutical

13.13.1 Dalian Yalifeng Bio-Pharmaceutical Company Information

13.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered

13.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Dalian Yalifeng Bio-Pharmaceutical Main Business Overview

13.13.5 Dalian Yalifeng Bio-Pharmaceutical Latest Developments

13.14 Sinopharm

13.14.1 Sinopharm Company Information

13.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Offered

13.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Sinopharm Main Business Overview

13.14.5 Sinopharm Latest Developments

14 Research Findings and Conclusion

Table 1. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Influenza Virus Vaccine (H1N1) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Intramuscular Vaccine

Table 4. Major Players of Nasal Spray Vaccine

Table 5. Global Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)

Table 6. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)

Table 7. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2022)

Table 9. Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2017-2022) & (US$/Dose)

Table 10. Global Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)

Table 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)

Table 12. Global Influenza Virus Vaccine (H1N1) Revenue by Application (2017-2022)

Table 13. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2017-2022)

Table 14. Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2017-2022) & (US$/Dose)

Table 15. Global Influenza Virus Vaccine (H1N1) Sales by Company (2020-2022) & (K Doses)

Table 16. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2020-2022)

Table 17. Global Influenza Virus Vaccine (H1N1) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2020-2022)

Table 19. Global Influenza Virus Vaccine (H1N1) Sale Price by Company (2020-2022) & (US$/Dose)

Table 20. Key Manufacturers Influenza Virus Vaccine (H1N1) Producing Area Distribution and Sales Area

Table 21. Players Influenza Virus Vaccine (H1N1) Products Offered

Table 22. Influenza Virus Vaccine (H1N1) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Influenza Virus Vaccine (H1N1) Sales by Geographic Region (2017-2022) & (K Doses)

Table 26. Global Influenza Virus Vaccine (H1N1) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Influenza Virus Vaccine (H1N1) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Influenza Virus Vaccine (H1N1) Sales by Country/Region (2017-2022) & (K Doses)

Table 30. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Influenza Virus Vaccine (H1N1) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)

Table 34. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)

Table 35. Americas Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)

Table 37. Americas Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)

Table 38. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)

Table 39. Americas Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)

Table 40. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)

Table 41. APAC Influenza Virus Vaccine (H1N1) Sales by Region (2017-2022) & (K Doses)

Table 42. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)

Table 43. APAC Influenza Virus Vaccine (H1N1) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2017-2022)

Table 45. APAC Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)

Table 46. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)

Table 47. APAC Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)

Table 48. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)

Table 49. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)

Table 50. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)

Table 51. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)

Table 53. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)

Table 54. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)

Table 55. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)

Table 56. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2017-2022) & (K Doses)

Table 58. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Type (2017-2022) & (K Doses)

Table 62. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Application (2017-2022) & (K Doses)

Table 64. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Influenza Virus Vaccine (H1N1)

Table 66. Key Market Challenges & Risks of Influenza Virus Vaccine (H1N1)

Table 67. Key Industry Trends of Influenza Virus Vaccine (H1N1)

Table 68. Influenza Virus Vaccine (H1N1) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Influenza Virus Vaccine (H1N1) Distributors List

Table 71. Influenza Virus Vaccine (H1N1) Customer List

Table 72. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2023-2028) & (K Doses)

Table 73. Global Influenza Virus Vaccine (H1N1) Sales Market Forecast by Region

Table 74. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2023-2028) & (K Doses)

Table 77. Americas Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Influenza Virus Vaccine (H1N1) Sales Forecast by Region (2023-2028) & (K Doses)

Table 79. APAC Influenza Virus Vaccine (H1N1) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2023-2028) & (K Doses)

Table 81. Europe Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Type (2023-2028) & (K Doses)

Table 85. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Influenza Virus Vaccine (H1N1) Sales Forecast by Application (2023-2028) & (K Doses)

Table 89. Global Influenza Virus Vaccine (H1N1) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Influenza Virus Vaccine (H1N1) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Influenza Virus Vaccine (H1N1) Revenue Market Share Forecast by Application (2023-2028)

Table 92. CSL Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 93. CSL Influenza Virus Vaccine (H1N1) Product Offered

Table 94. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 95. CSL Main Business

Table 96. CSL Latest Developments

Table 97. NVS(Novartis) Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 98. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Offered

Table 99. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 100. NVS(Novartis) Main Business

Table 101. NVS(Novartis) Latest Developments

Table 102. Sanofi Pasteur Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Offered

Table 104. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 105. Sanofi Pasteur Main Business

Table 106. Sanofi Pasteur Latest Developments

Table 107. Medimmune Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 108. Medimmune Influenza Virus Vaccine (H1N1) Product Offered

Table 109. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 110. Medimmune Main Business

Table 111. Medimmune Latest Developments

Table 112. GSK Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 113. GSK Influenza Virus Vaccine (H1N1) Product Offered

Table 114. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 115. GSK Main Business

Table 116. GSK Latest Developments

Table 117. Baxter Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 118. Baxter Influenza Virus Vaccine (H1N1) Product Offered

Table 119. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 120. Baxter Main Business

Table 121. Baxter Latest Developments

Table 122. Beijing Kexing Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 123. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered

Table 124. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 125. Beijing Kexing Bio-Vaccine Main Business

Table 126. Beijing Kexing Bio-Vaccine Latest Developments

Table 127. Hualan Bio-Vaccine Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 128. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Offered

Table 129. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 130. Hualan Bio-Vaccine Main Business

Table 131. Hualan Bio-Vaccine Latest Developments

Table 132. Changchun Changsheng Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 133. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered

Table 134. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 135. Changchun Changsheng Bio-Technology Main Business

Table 136. Changchun Changsheng Bio-Technology Latest Developments

Table 137. Beijing Tiantan Bio-Products Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 138. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Offered

Table 139. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 140. Beijing Tiantan Bio-Products Main Business

Table 141. Beijing Tiantan Bio-Products Latest Developments

Table 142. Jiangsu Yanshen Bio-Technology Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 143. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Offered

Table 144. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 145. Jiangsu Yanshen Bio-Technology Main Business

Table 146. Jiangsu Yanshen Bio-Technology Latest Developments

Table 147. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 148. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered

Table 149. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 150. Zhejiang Tianyuan Bio-Pharmaceutical Main Business

Table 151. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments

Table 152. Dalian Yalifeng Bio-Pharmaceutical Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 153. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Offered

Table 154. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 155. Dalian Yalifeng Bio-Pharmaceutical Main Business

Table 156. Dalian Yalifeng Bio-Pharmaceutical Latest Developments

Table 157. Sinopharm Basic Information, Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors

Table 158. Sinopharm Influenza Virus Vaccine (H1N1) Product Offered

Table 159. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)

Table 160. Sinopharm Main Business

Table 161. Sinopharm Latest Developments

List of Figures

Figure 1. Picture of Influenza Virus Vaccine (H1N1)

Figure 2. Influenza Virus Vaccine (H1N1) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Influenza Virus Vaccine (H1N1) Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Influenza Virus Vaccine (H1N1) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Influenza Virus Vaccine (H1N1) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Intramuscular Vaccine

Figure 10. Product Picture of Nasal Spray Vaccine

Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type in 2021

Figure 12. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2017-2022)

Figure 13. Influenza Virus Vaccine (H1N1) Consumed in 3 To 10 Years Old

Figure 14. Global Influenza Virus Vaccine (H1N1) Market: 3 To 10 Years Old (2017-2022) & (K Doses)

Figure 15. Influenza Virus Vaccine (H1N1) Consumed in 10 To 18 Years Old

Figure 16. Global Influenza Virus Vaccine (H1N1) Market: 10 To 18 Years Old (2017-2022) & (K Doses)

Figure 17. Influenza Virus Vaccine (H1N1) Consumed in Above 18 Years Old

Figure 18. Global Influenza Virus Vaccine (H1N1) Market: Above 18 Years Old (2017-2022) & (K Doses)

Figure 19. Influenza Virus Vaccine (H1N1) Consumed in Other

Figure 20. Global Influenza Virus Vaccine (H1N1) Market: Other (2017-2022) & (K Doses)

Figure 21. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2017-2022)

Figure 22. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application in 2021

Figure 23. Influenza Virus Vaccine (H1N1) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company in 2021

Figure 25. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2017-2022)

Figure 28. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)

Figure 30. Americas Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)

Figure 32. APAC Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)

Figure 34. Europe Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales 2017-2022 (K Doses)

Figure 36. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2021

Figure 38. Americas Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2021

Figure 39. United States Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Influenza Virus Vaccine (H1N1) Sales Market Share by Region in 2021

Figure 44. APAC Influenza Virus Vaccine (H1N1) Revenue Market Share by Regions in 2021

Figure 45. China Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2021

Figure 52. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2021

Figure 53. Germany Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country in 2021

Figure 60. Egypt Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Influenza Virus Vaccine (H1N1) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Influenza Virus Vaccine (H1N1) in 2021

Figure 66. Manufacturing Process Analysis of Influenza Virus Vaccine (H1N1)

Figure 67. Industry Chain Structure of Influenza Virus Vaccine (H1N1)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles